Europe In-vitro Diagnostics Market by Applications,Share & Growth Trends to 2024 - PowerPoint PPT Presentation

About This Presentation

Europe In-vitro Diagnostics Market by Applications,Share & Growth Trends to 2024


Europe in-vitro diagnostics market should experience substantial growth in the upcoming years due to increasing adoption of technologically advanced diagnostic equipment available. – PowerPoint PPT presentation

Number of Views:50


Transcript and Presenter's Notes

Title: Europe In-vitro Diagnostics Market by Applications,Share & Growth Trends to 2024


In-vitro Diagnostics Market in Europe is
projected to surpass 21 bn by 2024 Graphical
2018 Graphical Research. All rights

Key Insights from Europe In-vitro Diagnostics
  • According to Graphical Research, Europe In-vitro
    Diagnostics Market to reach 21 bn by 2024.
  • Improvement in healthcare infrastructure will
    drive Europe in-vitro diagnostics market growth.
    Majority of the population staying in developed
    countries rely on healthcare facilities developed
    by the public healthcare sector that has lower
    cost structure thereby will escalate demand for
    cost-effective diagnostic services augmenting
    industry growth.
  • Regulations implemented by the European
    Diagnostic Clusters Alliance (EDCA) has enforced
    specific guidelines for manufacturers of the
    in-vitro diagnostics tools and equipment to meet
    patients safety demand thereby will augment
    in-vitro diagnostic industry growth.
  • In-vitro diagnostic instruments segment will grow
    at 4.9 during the forecast timeframe owing to
    increasing number of laboratories equipped with
    instruments of superior quality. According to
    Global Genes, more than 30 million people suffer
    from rare diseases in Europe that require
    critical monitoring and diagnosis at gene level
    that should escalate the demand for diagnostic

2018 Graphical Research. All rights

  • In-vitro diagnostic services segment held an
    enormous share of 78.9 in 2017 and is projected
    to grow significantly over the forecast timeframe
    as a result of growing geriatric population
    globally that will augment demand for in-vitro
    diagnostic services influencing the segmental
    growth positively.
  • Immunoassays or immunochemistry segment was
    valued at USD 3.0 billion in 2017 and high growth
    can be accounted to various benefits offered by
    these tests.
  • Cardiology segment will grow at 5.9 during the
    forecast timeline as a result of increasing
    incidence of cardiovascular diseases due to
    tobacco smoking, lack of physical activity,
    consumption of alcohol and unhealthy diet that
    will drive the segmental growth.
  • Laboratories segment held enormous revenue share
    of 29.4 in 2017 due to presence of various
    growth opportunities such as availability of
    skilled labor to work increasing the level of
    operational efficiency. High preference for
    laboratories with well-equipped diagnostic
    machines and equipment will thereby propel the
    segment growth.

2018 Graphical Research. All rights

  • Germany in-vitro diagnostics industry was valued
    at USD 2.1 billion in 2017 and is expected to
    grow exponentially over the estimated timeframe
    owing to the increasing number of technological
    advancements that are being incorporated in the
    medical diagnostic devices. For instance, major
    industry players such as Roche diagnostics have
    developed clinical diagnostic solutions and
    devices integrated with advanced technology
    enabling automation and increasing the
    operational efficiency that will thereby boost
    the preference for clinical chemistry, blood gas
    analysis and other such analytical devices that
    will stimulate the industry growth.
  • Major industry competitors operating in Europe
    in-vitro diagnostics market are Abbott, Becton
    Dickinson, BioRad, BioMerieux, Cephied, Danaher,
    Grifols, Johnson Johnson, Luminex, Roche
    Diagnostics, Siemens, Sorin, Thermo Fisher and
    Qiagen. These industry players have adopted
    certain strategic initiatives to gain competitive
    advantage and achieve sustainable profits. For
    instance, in January 2017, Grifols acquired
    Hologic unit working in RD facility
    manufacturing assays and instruments based on
    nucleic acid testing technology. This acquisition
    will help in expanding the companys product

2018 Graphical Research. All rights

Europe In-vitro Diagnostics Market
2018 Graphical Research. All rights

Browse Full Market Research Report On Europe
In-vitro Diagnostics Market  _at_ https//
9tAPG Request for a Sample of this Research
Report _at_ https//
2018 Graphical Research. All rights

Stay In Touch With Us For
Website Socia
l Media
Assured Quality
On-Time Delivery
Industry Experts
Payment Security
2018 Graphical Research. All rights
Write a Comment
User Comments (0)